Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Verteporfin proven safe in phase III trials

May 15, 1998

Vitrase shown to clear vitreous hemorrhage

May 15, 1998

Akorn launches generic cromolyn sodium

May 12, 1998

VISX Excimer Laser System approved in Japan

May 11, 1998

Novo Nordisk discovers potent sst4 receptor agonist

May 5, 1998

First market introduction for Alcon's newest ophthalmic drug

May 5, 1998

Update on Repligen's angiogenesis inhibitors

May 1, 1998

CyDex and Allergan sign option for ophthalmic drug delivery technology

April 29, 1998

New antiglaucoma agent approved in U.S.

April 24, 1998

Another European launch for Alphagan

April 23, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...